Homologous recombination deficiency (HRD) scoring in pancreatic ductal adenocarcinoma (PDAC) and response to chemotherapy

被引：0
|
作者：
O'Kane, Grainne M.
Denroche, Rob
Picardo, Sarah Louise
Zhang, Amy
Holter, Spring
Grant, Robert C.
Allen, Michael
Wang, Yifan
Dodd, Anna
Ramotar, Stephanie
Hutchinson, Shawn
Tehfe, Mustapha
Biagi, James Joseph
Wilson, Julie
Notta, Faiyaz
Fischer, Sandra
Zogopoulos, George
Gallinger, Steven
Knox, Jennifer J.
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Ontario Inst Canc Res, Toronto, ON, Canada
[3] Beaumont Hosp, Dept Med Oncol, Dublin, Ireland
[4] Ontario Inst Canc Res, Toronto, ON, Canada
[5] Samuel Lunenfeld Res Inst, Toronto, ON, Canada
[6] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[7] McGill Univ, Montreal, PQ, Canada
[8] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[9] CHU Montreal, Hop Notre Dame, Montreal, PQ, Canada
[10] Queens Univ, Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[11] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
[12] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[13] Toronto Gen Hosp, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
741
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
    Michalak, Natalia
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [32] Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).
    Krantz, Benjamin A.
    Tsui, Dana
    Lowery, Maeve Aine
    Capanu, Marinela
    Yu, Kenneth H.
    Kelsen, David Paul
    Gedvilaite, Erika
    Zhang, Liguo
    Selcuklu, S. Duygu
    You, Daoqi
    Pernicka, Jennifer S. Golia
    Do, Richard K. G.
    Iacobuzio-Donahue, Christine A.
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [33] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    MODERN PATHOLOGY, 2018, 31 : 680 - 680
  • [34] pH Regulatory Transporters in Pancreatic Ductal Adenocarcinoma (PDAC)
    Kong, Su Chii
    Christensen, Sandra
    Hoffmann, Else Kay
    Novak, Ivana
    Pedersen, Stine Falsig
    FASEB JOURNAL, 2013, 27
  • [35] Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
    Martinez-Muniz, Andres E.
    Sivanand, Sharanya
    Vander Heiden, Matthew
    CANCER RESEARCH, 2019, 79 (13)
  • [36] Homologous recombination repair gene mutations in Chinese pancreatic ductal adenocarcinoma patients.
    Ke, Nengwen
    Yan, Maolin
    Che, Xu
    Cheng, Yu
    Wang, Zheng
    Wu, Zheng
    Song, RongFeng
    Xu, Guohui
    Wang, Yan
    Wang, Junwei
    Zhao, Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] HOMOLOGOUS RECOMBINATION DEFICIENCY (HRD) SCORE IN CHINESE AGGRESSIVE PROSTATIC ADENOCARCINOMA WITH OR WITHOUT INTRADUCTAL CARCINOMA OF THE PROSTATE
    Zhu, Sha
    Zeng, Hao
    JOURNAL OF UROLOGY, 2022, 207 (05): : E630 - E631
  • [38] Safety and efficacy of chemotherapy in older adults with locally advanced and metastatic pancreatic ductal adenocarcinoma (PDAC)
    Ostios-Garcia, Lorena
    Saade, Patricia
    Grossman, Joseph Elan
    Lanniello, Leanne
    Bullock, Andrea J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [39] Stochasticity in threshold of homologous recombination deficiency (HRD) score.
    Xu, Bai
    Xu, Bai
    Kai, Zhentian
    Thi, Phuong Anh Nguyen
    Xia, Chaoran
    Shi, Weiwei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17561 - E17561
  • [40] Keratin 17 as a predictor of chemotherapy response in pancreatic ductal adenocarcinoma
    Oblein, Lyanne
    Roa, Lucia
    Babu, Sruthi
    Horowitz, Michael
    Petricoin, Emanuel
    Matrisian, Lynn M.
    Blais, Edik
    Marchenko, Natalia
    Allard, Felicia
    Alkalin, Ali
    Jiang, Wei
    Larson, Brent
    Hendifar, Andrew
    Picozzi, Vincent
    Choi, Minsig
    Escobar-Hoyos, Luisa
    Shroyer, Kenneth
    CANCER RESEARCH, 2024, 84 (02)
12345